SPECIAL NOTICE
A -- Production of Botulinum Toxin Anti-Immunoglobulin
- Notice Date
- 6/5/2002
- Notice Type
- Special Notice
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Institutes of Allergy and Infectious Diseases, Contract Management Branch 6700-B Rockledge Drive, MSC 7612 Room 2230, Bethesda, MD, 20892-7612
- ZIP Code
- 20892-7612
- Solicitation Number
- Reference-Number-N0T-AI-02-02
- Response Due
- 7/12/2002
- Archive Date
- 7/27/2002
- Point of Contact
- Barbara Shadrick, Senior Contracting Officer, Phone 301-496-7288, Fax 301-402-0972,
- E-Mail Address
-
bs92y@nih.gov
- Description
- The National Institute of Allergy and Infectious Diseases (NIAID) is interested in supporting the development and licensure of botulinum toxin anti-immunoglobulin as a part of our Biodefense program. NIAID is interested in receiving letters from organizations that have the needed development and production capabilities. Interested organizations should submit a letter of interest that contains a detailed description of a potential development, production and marketing plan, as well as their R&D capabilities and interest. The letter of interest along with any supporting documentation shall not exceed 10 pages. Letters of interest will be kept confidential and will help in determining the need for an RFP to support further development, testing, and licensure of these products, and in assembling a potential source list for distribution if an RFP is issued. Submit your response to Barbara Shadrick at the address listed in this Special Notice.
- Place of Performance
- Address: United States
- Record
- SN00088220-W 20020607/020605214002 (fbodaily.com)
- Source
-
FedBizOpps.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |